New Patent Could Be Worth $6 A Share To Amgen - Yahoo! News
Links shared publicly online about this topic.
- 0total visits
New Patent Could Be Worth $6 A Share To Amgen - Yahoo! News
From Yahoo! News: Geoffrey Porges and his team of analysts at Sanford C. Bernstein took another look at the patent Amgen was issued last week on the top-selling drug Enbrel, used to treat rheumatoid arthritis, psoriasis, and other immune diseases. They found that the patent was more valuable than it initially appeared, because [...]
View full resource at news.yahoo.com
Tags: Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Drug, Enbrel, Amgen, News
Most Recently Shared on November 28, 2011 at 2:58 pm By:
New Patent Could Be Worth $6 A Share To Amgen: Geoffrey Porges and his team of analysts at Sanford C. Bernstein ... http://t.co/JbWWuK5t
Advertisement
